XIAO FANG ORD A (SHH) EQSW Exp: (603207.SS) stock: key figures, P/E, revenue and dividend

Health Care · China

Price
22.53 CNY
Market cap
3.62 bn CNY
P/E (2025)
17.43
P/S (2025)
6.89
Dividend yield
3.37 %
Net margin
39.50 %
Return on equity (ROE)
18.99 %
Return on assets (ROA)
16.74 %

XIAO FANG ORD A (SHH) EQSW Exp: financials

Fiscal year20242025
Revenue474.58 m CNY525.28 m CNY
Gross profit311.39 m CNY341.43 m CNY
Operating income234.12 m CNY240.37 m CNY
EBIT239.53 m CNY241.25 m CNY
Net income205.27 m CNY207.49 m CNY
Diluted EPS – continuing operations1.28 CNY1.29 CNY

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About XIAO FANG ORD A (SHH) EQSW Exp:

Shanghai Xiao Fang Pharmaceutical Co.,Ltd. produces and sells medicines in China and internationally. It offers medicines in the areas of gastroenterology, dermatology, orthopedics, ENT, and disinfection. It also engages in the family health management business. The company was founded in 1993 and is based in Shanghai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.